Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Local protein kinase A signaling pathologies in the endocrine system.

Molecular pharmacology·2026
Same author

The β<sub>2</sub>-adrenoceptor agonist formoterol attenuates hallmarks of adrenal Cushing's syndrome.

British journal of pharmacology·2026
Same author

AKAP2 is required for assembly of cytoskeletal signaling complexes that promote growth and metastasis of triple-negative breast cancer.

The Journal of biological chemistry·2026
Same author

Correction: Characterization of Post-Viral Infection Behaviors Among Patients With Long COVID: Prospective, Observational, Longitudinal Cohort Analyses of Fitbit Data and Patient-Reported Outcomes.

JMIR formative research·2026
Same author

Characterization of Post-Viral Infection Behaviors Among Patients With Long COVID: Prospective, Observational, Longitudinal Cohort Analyses of Fitbit Data and Patient-Reported Outcomes.

JMIR formative research·2025
Same author

Conditionally Active CD28xVISTA Bispecific Antibodies Promote Myeloid-Driven T-cell Activation.

Cancer immunology research·2025

Related Experiment Video

Updated: Jun 4, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Plugging PKA into ERK scaffolds.

F Donelson Smith, Lorene K Langeberg, John D Scott

    Cell Cycle (Georgetown, Tex.)
    |February 12, 2011
    PubMed
    Summary
    This summary is machine-generated.

    Aberrant ERK kinase activation, common in cancers due to Ras/B-Raf mutations, is organized by AKAP-Lbc. This scaffold protein enhances signaling efficiency by directing PKA phosphorylation of KSR-1.

    More Related Videos

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
    08:40

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

    Published on: November 29, 2016

    Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
    10:41

    Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

    Published on: June 7, 2019

    Related Experiment Videos

    Last Updated: Jun 4, 2026

    Assaying Protein Kinase Activity with Radiolabeled ATP
    08:05

    Assaying Protein Kinase Activity with Radiolabeled ATP

    Published on: May 26, 2017

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
    08:40

    Spatial and Temporal Analysis of Active ERK in the C. elegans Germline

    Published on: November 29, 2016

    Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy
    10:41

    Visualizing Protein Kinase A Activity In Head-fixed Behaving Mice Using In Vivo Two-photon Fluorescence Lifetime Imaging Microscopy

    Published on: June 7, 2019

    Area of Science:

    • Molecular biology
    • Cell signaling
    • Cancer research

    Background:

    • Aberrant protein kinase signaling, particularly involving Ras/B-Raf mutations leading to ERK activation, is a hallmark of many human cancers.
    • Scaffolding and anchoring proteins play crucial roles in organizing kinase signaling networks, influencing signal processing dynamics.

    Discussion:

    • AKAP-Lbc acts as a scaffold, associating with KSR-1 to form a signaling network responsive to growth factors and cAMP.
    • AKAP-Lbc's interaction with KSR-1 is critical for organizing this network and ensuring efficient signal transduction.

    Key Insights:

    • AKAP-Lbc directs Protein Kinase A (PKA) phosphorylation of KSR-1 at a key residue.
    • This directed phosphorylation by AKAP-Lbc is essential for maximizing the efficiency of the ERK signaling pathway.

    Outlook:

    • Understanding AKAP-Lbc's role in scaffolding ERK signaling could reveal new therapeutic targets for cancers driven by Ras/B-Raf pathway mutations.
    • Further research into AKAP-Lbc-mediated scaffolding may uncover novel strategies for modulating kinase signaling in oncology.